Regulatory Post-Marketing Surveillance Study for TETRAXIM™

NCT01437423 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Poliomyelitis

Interventions

BIOLOGICAL: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio

Sponsor

Sanofi Pasteur, a Sanofi Company